The major disadvantages of the study were as follows: firstly, due to the sample size (N = 547), large-scale subgroup analysis based on comparing the intensity of association between diabetic and non-diabetic patients will further demonstrate the importance of ACE2 in T2D patients. This evidence concerns the gene ACE2 and type 2 diabetes mellitus.